
About Croient Pharma Private Limited
Data last updated:
Croient Pharma Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 February 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2012PTC226900. Its GSTIN is 27AAECC7191B1ZS (Maharashtra).
The company has an authorised share capital of ₹45 Lakh and a paid-up capital of ₹40.5 Lakh. It is led by directors including Shrikant Hambirrao Rane and Pawankumar Babasaheb Ankalkope.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 2 Srushti Society Kolbad Road Thane (West), Maharashtra, India – 400601.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.13 Cr, a growth of 76% compared to the previous year. For the same year it recorded a net profit of ₹1.5 Cr (net margin 7.8%) and EBITDA of ₹2.75 Cr (EBITDA margin 14.4%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 30% over five years.
The company is associated with 1 brand: Croient Pharma. As per MCA filings, the company has open charges of ₹13.05 Cr and satisfied charges of ₹3.1 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website croientpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressShop No. 2 Srushti Society Kolbad Road Thane (West), Maharashtra, India – 400601
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Croient Pharma Private Limited
Croient Pharma operates one associated brand: Croient Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and exports pharmaceutical products, cosmetics, and nutraceuticals to global importers. | croientpharma.com |
Competitors & Alternatives of Croient Pharma Private Limited
Brands and companies operating in the same space as Croient Pharma Private Limited include WuXi AppTec, ANI Pharmaceuticals, Aptar and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
| | Provider of CRO and CDMO services | Shanghai, China | 2000 |
| | Branded and generic prescription drugs are developed, manufactured, and marketed. | Baudette, United States | 1996 |
| | Regulatory support, brand differentiation, and prototyping services are provided. | Crystal Lake, United States | 1992 |
| | Branded pharmaceutical products are developed, marketed, and distributed globally. | Mesekenhagen, Germany | 1998 |
| | Advisory, scientific, and medical communications provided for pharmaceutical industry. | Yardley, United States | 2014 |
| | Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes | 1929 | |
| | Laboratory testing and contract research services are provided globally. | Luxembourg | 1987 |
| | Generic formulations including tablets, capsules, liquids, and injectables are manufactured. | Shenzhen, China | 1992 |
| | Provider of drug research & development services for multiple therapeutic areas | Boston, United States | 2021 |
Business Activity of Croient Pharma Private Limited
The main business activity of Croient Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Croient Pharma Private Limited
Croient Pharma Private Limited is audited by Prince Jain & Co for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Prince Jain & Co | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Croient Pharma Private Limited
Croient Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shrikant Hambirrao Rane Also directs: Ransaw Remedies Private Limited | Director | 14 Feb 2012 | 14 Years 7 Months | Current |
| Pawankumar Babasaheb Ankalkope | Director | 14 Feb 2012 | 14 Years 7 Months | Current |
| Dinesh Balkrishna Sawant Also directs: Ransaw Remedies Private Limited | Director | 14 Feb 2012 | 14 Years 7 Months | Current |
Financials of Croient Pharma Private Limited FY 2025 filings available
Croient Pharma Private Limited reported revenue of ₹19.13 Cr (up 76% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Croient Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 76% growth in the latest year. EBITDA rose 103% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Croient Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹19.13 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.75 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.5 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Croient Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 7.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Croient Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Croient Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Croient Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jul 2023 | Axis Bank Limited | ₹6.25 Cr | Open |
| 12 Jun 2023 | Others | ₹80 Lakh | Open |
| 30 Jul 2019 | Others | ₹6 Cr | Open |
| 06 Sep 2018 | Others | ₹2.5 Cr | Satisfied |
| 02 Jan 2018 | Others | ₹60 Lakh | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Croient Pharma Private Limited
Employment history and EPFO contributions of people linked to Croient Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Croient Pharma Private Limited
Croient Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECC7191B1ZS | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Croient Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Croient Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Croient Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Croient Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Croient Pharma Private Limited
Frequently Asked Questions about Croient Pharma Private Limited
Croient Pharma is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 February 2012 (14+ years old) and is registered under CIN U24233MH2012PTC226900.
Croient Pharma reported revenue of ₹19.13 Cr for FY 2024 (up 76% YoY).
Croient Pharma has 3 current directors:
- Shrikant Hambirrao Rane - Director
- Pawankumar Babasaheb Ankalkope - Director
- Dinesh Balkrishna Sawant - Director
Croient Pharma reported a net profit of ₹1.5 Cr (net margin 7.8%) and EBITDA of ₹2.75 Cr (EBITDA margin 14.4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Croient Pharma is 23% over three years and 30% over five years. In the latest year (FY 2024) revenue rose 76%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Croient Pharma is 27AAECC7191B1ZS, registered in Maharashtra.
The CIN (Corporate Identification Number) of Croient Pharma is U24233MH2012PTC226900. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Croient Pharma was incorporated on 14 February 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
Croient Pharma can be reached through the website croientpharma.com. Its registered office is in Thane, Maharashtra, India.